Clinical Trials Logo

Clinical Trial Summary

Vancomycin, a novel intravenously administered antibiotic, currently plays a key role in the management of complicated multi-organism infections. However,current LC-MS/MS methods briefly describe parameters and the only reported internal standard was sometimes difficult to obtain. In our study,an updated LC-MS/MS method for the quantitative analysis of vancomycin in human serum was developed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03585426
Study type Interventional
Source Xijing Hospital
Contact
Status Enrolling by invitation
Phase Phase 4
Start date March 2016
Completion date December 2018

See also
  Status Clinical Trial Phase
Recruiting NCT03221023 - Intrawound Vancomycin Prophylaxis for Neural Stimulator Phase 2/Phase 3
Recruiting NCT03456544 - Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
Not yet recruiting NCT05964114 - First Time Right of Vancomycin N/A
Completed NCT02951702 - Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics Phase 4
Completed NCT05535075 - Model-informed Precision Dosing of Vancomycin in Adults Phase 4
Active, not recruiting NCT04911270 - Clinical Decision Support Tool for Vancomycin Dosing in Children N/A
Recruiting NCT05823116 - Continuous vs. Intermittent Infusion Vancomycin Phase 4
Recruiting NCT02456974 - Antibiotic Dosing in Pediatric Intensive Care
Recruiting NCT05257070 - The Clinical Validation of a Dried Blood Spot Method for Vancomycin and Creatinine
Completed NCT04756895 - Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population N/A
Suspended NCT02590523 - Intracameral Antibiotic Safety Study Phase 3
Completed NCT03806543 - The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level
Recruiting NCT04758442 - Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology N/A
Completed NCT04042233 - Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol Phase 4
Active, not recruiting NCT04666948 - Precision Dosing of Vancomycin in Critically Ill Children Phase 4
Recruiting NCT02667418 - Optimal Treatment for Recurrent Clostridium Difficile Phase 4
Recruiting NCT06069206 - Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes N/A
Completed NCT03453684 - Pharmacokinetics of Preoperative Vancomycin Phase 4
Recruiting NCT06426836 - Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO) N/A